Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.71 - $19.57 $2,710 - $19,570
-1,000 Reduced 5.71%
16,500 $46,000
Q4 2023

Jan 30, 2024

BUY
$12.07 - $18.46 $211,225 - $323,050
17,500 New
17,500 $257,000
Q1 2023

Aug 02, 2023

BUY
$27.71 - $40.93 $340,833 - $503,439
12,300 New
12,300 $360,000
Q1 2023

Apr 27, 2023

BUY
$27.71 - $40.93 $216,138 - $319,254
7,800 Added 173.33%
12,300 $360,000
Q4 2022

Jan 26, 2023

BUY
$29.75 - $39.26 $98,175 - $129,558
3,300 Added 275.0%
4,500 $166,000
Q2 2022

Jul 25, 2022

SELL
$6.85 - $19.93 $7,535 - $21,923
-1,100 Reduced 47.83%
1,200 $23,000
Q1 2022

Apr 21, 2022

BUY
$12.85 - $32.9 $29,555 - $75,670
2,300 New
2,300 $29,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.